<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01762085</url>
  </required_header>
  <id_info>
    <org_study_id>WIRB 20122035</org_study_id>
    <secondary_id>Nerve DURA</secondary_id>
    <nct_id>NCT01762085</nct_id>
  </id_info>
  <brief_title>Nerve Decompression for Ulcer Recurrence Avoidance (DURA)</brief_title>
  <acronym>DURA</acronym>
  <official_title>A Prospective Study of Recurrence Risk in Diabetic Foot Ulceration After Nerve Decompression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association of Extremity Nerve Surgeons</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association of Extremity Nerve Surgeons</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anecdotal reports and scientific literature suggest that the risk of recurrence of diabetic
      foot ulcers can be minimized by nerve decompression procedures at anatomic sites of nerve
      pinching and entrapment. Historical risk of 25% annually has been reported to decrease by
      &gt;80% to under 5% yearly. Since an open wound precedes the large majority (85%) of amputations
      in diabetes, avoidance of ulcer recurrences is important. This study tests the current
      academic opinion that nerve decompression will not decrease ulcer recurrence risk. Null
      hypothesis: nerve decompression will not decrease diabetic foot ulcer recurrence risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diabetes patients with a recently healed, non-ischemic plantar diabetic foot ulcer will be
      randomized to &quot;best care&quot; standard post-ulcer treatment or to best care plus bilateral nerve
      decompression by external neurolysis at 4 fibro-osseous tunnel sites in the leg and foot.
      Comparison of the control group with standard care to the surgical intervention group will be
      made for subsequent appearance of a plantar foot ulcer and ulcer recurrence risks will be
      calculated. Additional subjective and objective secondary outcomes will be monitored. Null
      hypothesis: nerve decompression will not decrease diabetic foot ulcer recurrence risk.

      If protection against ulcer occurrence were to be confirmed, a change in the treatment
      paradigm for diabetic neuropathy and foot ulcer could be appropriate.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of plantar foot ulceration wound</measure>
    <time_frame>2 years post-enrollment or post-op</time_frame>
    <description>Non- traumatic pressure wound or ulcer appearance during the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>occurrence of delayed wound healing</measure>
    <time_frame>3 months post nerve decompression</time_frame>
    <description>failure of surgical wound to heal primarily, without local infection signs of swelling, heat, redness, and pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Score</measure>
    <time_frame>2 years</time_frame>
    <description>Patient report of pain level</description>
  </secondary_outcome>
  <other_outcome>
    <measure>any amputation</measure>
    <time_frame>24 months, 2 years</time_frame>
    <description>surgical removal of any part of the lower extremity, including toe</description>
  </other_outcome>
  <other_outcome>
    <measure>surgical wound infection</measure>
    <time_frame>3 months</time_frame>
    <description>swelling, redness, or heat, with pain after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>non-surgical foot infection</measure>
    <time_frame>24 months</time_frame>
    <description>foot swelling, redness, pain, and heat not subsequent to operation; or occurring in an operated leg &gt;90 days post-op</description>
  </other_outcome>
  <other_outcome>
    <measure>measures of diabetic peripheral neuropathy (DPN)</measure>
    <time_frame>2 years</time_frame>
    <description>Michigan Neuropathy Symptom Index; Pain visual analog pain scale (VAPS); sensibility to vibration, light touch, 2-point discrimination; deep tendon reflex</description>
  </other_outcome>
  <other_outcome>
    <measure>analgesic usage</measure>
    <time_frame>2 years</time_frame>
    <description>patients will log use of analgesic medications and changes in use.</description>
  </other_outcome>
  <other_outcome>
    <measure>SPY Indocyanine green circulation evaluation</measure>
    <time_frame>pre-opo, post-op, study end</time_frame>
    <description>This intravenous injection and non-invasive scan evaluation may indicate whether relief of nerve entrapment will alter macro or microcirculation</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of falls during the study</measure>
    <time_frame>2 years</time_frame>
    <description>Prior history of falls will be defined and changes in risk of new falls in control and intervention groups. Balance has been reported to improve after nerve decompression.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Diabetic Ulcer of Plantar Aspect of Left Foot</condition>
  <condition>Diabetic Ulcer of Plantar Aspect of Right Foot</condition>
  <condition>Diabetic Polyneuropathy</condition>
  <arm_group>
    <arm_group_label>healed DFU control arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>clinic-specific usual &quot;best care&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healed DFU surgical intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>clinic-specific &quot;best care&quot; plus nerve decompression at 4 known sites of lower leg fibro-osseous entrapment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nerve decompression</intervention_name>
    <description>surgical decompression involves surgical division or incision of perineural fibrous or fibro-osseous tunnel tissues which pinch, choke, compress or sharply deviate nerve trunks.</description>
    <arm_group_label>healed DFU surgical intervention</arm_group_label>
    <other_name>nerve release</other_name>
    <other_name>external neurolysis</other_name>
    <other_name>surgical decompression</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 or Type 2 Diabetes Mellitus

          -  Diabetic sensorimotor peripheral neuropathy

          -  Recently healed plantar neuropathic Diabetic Foot Ulcer (&lt; 18 months)

          -  At least one palpable foot or ankle pulse or ABI&gt;0.8 bilaterally.

          -  Recent Hgb A1c &lt; 9.0%

          -  Ankle edema absent or mild

        Exclusion Criteria:

          -  Ischemic peripheral vascular disease or ankle-brachial index (ABI)&lt;0.8

          -  History of peripheral vascular arterial surgery

          -  History of peripheral nerve or lumbar disc surgery

          -  alcohol abuse(more than 2 drinks/day)

          -  untreated thyroid disorders

          -  B12 or Folate deficiency

          -  spondyloarthropathies

          -  hepatic disease

          -  advanced renal disease

          -  current lumbosacral radiculopathy or nerve compression

          -  toxin exposure including chemotherapeutic agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>D. Scott Nickerson, MD</last_name>
    <role>Study Director</role>
    <affiliation>NE Wyoming Wound Care Center, consultant</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen L. Barrett, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barrett Foot &amp; Ankle Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephen Barrett, DPM</last_name>
    <phone>623 572-3456</phone>
    <email>slbarrettpod@me.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>D. Scott Nickerson, MD</last_name>
    <phone>307 752-9875</phone>
    <email>thenix@fiberpipe.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Barrett Foot &amp; Ankle Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven L Barrett, DPM</last_name>
      <phone>480-478-0780</phone>
      <email>slbarrettpod@me.com</email>
    </contact>
    <contact_backup>
      <last_name>John C Tassone, DPM</last_name>
      <phone>(602) 938-6960</phone>
      <email>jctassone@cox.net</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen L Barrett, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richard P. Jacoby</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard P Jacoby, DPM</last_name>
      <phone>480-994-5977</phone>
      <email>jacobydpm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Richard P Jacoby, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Arizona Limb Salvage Alliance,</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724-5072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manish Bharara, PhD</last_name>
      <phone>520-626-1349</phone>
      <email>manish.bharara@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>David Armstrong, DPM</last_name>
      <phone>(520) 626-1349</phone>
    </contact_backup>
    <investigator>
      <last_name>Manish Bharara, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Andrew Rader, DPM</name>
      <address>
        <city>Jasper</city>
        <state>Indiana</state>
        <zip>47546</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew P Rader, DPM</last_name>
      <phone>812-634-2778</phone>
      <email>pvppc@psci.net</email>
    </contact>
    <investigator>
      <last_name>Andrew P Rader, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Damien Dauphinee</name>
      <address>
        <city>Denton</city>
        <state>Texas</state>
        <zip>76210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damien Dauphinee, DPM</last_name>
      <phone>940-300-3054</phone>
      <email>dauphinee@completefootandanklecare.com</email>
    </contact>
    <investigator>
      <last_name>Damien Dauphinee, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maria Buitrago, DPM</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77092</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Buitrago, DPM</last_name>
      <phone>713-680-3668</phone>
      <email>mobui@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Buitrago, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aszmann O, Tassler PL, Dellon AL. Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure. Ann Plast Surg. 2004 Dec;53(6):517-22.</citation>
    <PMID>15602245</PMID>
  </reference>
  <reference>
    <citation>Dellon AL. Preventing foot ulceration and amputation by decompressing peripheral nerves in patients with diabetic neuropathy. Ostomy Wound Manage. 2002 Sep;48(9):36-45. Review.</citation>
    <PMID>12271732</PMID>
  </reference>
  <reference>
    <citation>Dellon AL. Neurosurgical prevention of ulceration and amputation by decompression of lower extremity peripheral nerves in diabetic neuropathy: update 2006. Acta Neurochir Suppl. 2007;100:149-51.</citation>
    <PMID>17985566</PMID>
  </reference>
  <reference>
    <citation>Nickerson DS. Low recurrence rate of diabetic foot ulcer after nerve decompression. J Am Podiatr Med Assoc. 2010 Mar-Apr;100(2):111-5.</citation>
    <PMID>20237362</PMID>
  </reference>
  <reference>
    <citation>Dellon AL, Muse VL, Nickerson DS, Akre T, Anderson SR, Barrett SL, Biddinger KR, Bregman PJ, Bullard BP, Dauphinee DM, DeJesus JM, DeJesus RA, Ducic I, Dunkerly J, Galina MR, Hung V, Ichtertz DR, Kutka MF, Jacoby RP, Johnson JB, Mader DW, Maloney CT Jr, Mancuso PJ, Martin RC, Martin RF, McDowel BA, Rizzo VJ, Rose M, Rosson GD, Shafiroff BB, Steck JK, Stolarski RG, Swier P, Wellens-Bruschayt TA, Wilke B, Williams EH, Wood MA, Wood WA, Younes MP, Yuksel F. Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy. J Reconstr Microsurg. 2012 May;28(4):241-6. doi: 10.1055/s-0032-1306372. Epub 2012 Mar 12.</citation>
    <PMID>22411624</PMID>
  </reference>
  <reference>
    <citation>Dellon AL. A cause for optimism in diabetic neuropathy. Ann Plast Surg. 1988 Feb;20(2):103-5.</citation>
    <PMID>3355053</PMID>
  </reference>
  <reference>
    <citation>Dellon AL. Treatment of symptomatic diabetic neuropathy by surgical decompression of multiple peripheral nerves. Plast Reconstr Surg. 1992 Apr;89(4):689-97; discussion 698-9.</citation>
    <PMID>1546082</PMID>
  </reference>
  <reference>
    <citation>Rankin TM, Miller JD, Gruessner AC, Nickerson DS. Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration. J Diabetes Sci Technol. 2015 Jul;9(4):873-80. doi: 10.1177/1932296815584796. Epub 2015 Jun 8.</citation>
    <PMID>26055081</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2013</study_first_submitted>
  <study_first_submitted_qc>January 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2013</study_first_posted>
  <last_update_submitted>June 25, 2015</last_update_submitted>
  <last_update_submitted_qc>June 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>neuropathic diabetic foot ulcer</keyword>
  <keyword>nerve decompression surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Polyneuropathies</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

